E-LIB Suche - Ergebnisse für: Lafontan, M

1

Adipose tissue and adipocyte dysregulation:

Lafontan, M.
Diabetes & Metabolism. 40 (2014) 1 - p. 16-28 , 2014

Link: https://doi.org/10.1016/..

2

ISP9: Not all fat is bad in cardiovascular risk. Mechanisti..:

Lafontan, M.
Diabetes & Metabolism. 38 (2012) - p. S91 , 2012

Link: https://doi.org/10.1016/..

3

Recommendations for healthier hydration: addressing the pub..:

Armstrong, L. E. ; Barquera, S. ; Duhamel, J. ‐F....
Clinical Obesity. 2 (2012) 5-6 - p. 115-124 , 2012

Link: https://doi.org/10.1111/..

4

Hormones et obésité:

Lafontan, M.
Annales d'Endocrinologie. 73 (2012) 4 - p. 249 , 2012

Link: https://doi.org/10.1016/..

5

L'adipocyte ou la revanche du Petit Chose:

Lafontan, M.
Annales d'Endocrinologie. 73 (2012) 4 - p. 237 , 2012

Link: https://doi.org/10.1016/..

6

Adrenaline but not noradrenaline is a determinant of exerci..:

De Glisezinski, I. ; Larrouy, D. ; Bajzova, M....
The Journal of Physiology. 587 (2009) 13 - p. 3393-3404 , 2009

Link: https://doi.org/10.1113/..

7

B003 Caractérisation des cellules endothéliales du tissu ad..:

Villaret, A. ; Danoux, L. ; Jeanmaire, C....
Archives of Cardiovascular Diseases. 102 (2009) - p. S21 , 2009

Link: https://doi.org/10.1016/..

8

O20 Différence de lipolyse entre le tissu adipeux sous-cuta..:

de Glisezinski, I. ; Marques, M.A. ; Mairal, A....
Diabetes & Metabolism. 35 (2009) - p. A6 , 2009

Link: https://doi.org/10.1016/..

9

Impact of visceral adipose tissue on liver metabolism:

Lafontan, M. ; Girard, J.
Diabetes & Metabolism. 34 (2008) 4 - p. 317-327 , 2008

Link: https://doi.org/10.1016/..

10

Impact of visceral adipose tissue on liver metabolism and i..:

Girard, J. ; Lafontan, M.
Diabetes & Metabolism. 34 (2008) 5 - p. 439-445 , 2008

Link: https://doi.org/10.1016/..

11

Use of the microdialysis technique to assess lipolytic resp..:

Monteux, C ; Lafontan, M
Journal of the European Academy of Dermatology and Venereology. 22 (2008) 12 - p. 1465-1470 , 2008

Link: https://doi.org/10.1111/..

12

Atrial natriuretic peptide inhibits the production of adipo..:

Moro, C. ; Klimcakova, E. ; Lolmède, K....
Diabetologia. 50 (2007) 5 - p. 1038-1047 , 2007

Link: https://doi.org/10.1007/..

13

Phosphodiesterase‐5A and neutral endopeptidase activities i..:

Moro, C ; Klimcakova, E ; Lafontan, M..
British Journal of Pharmacology. 152 (2007) 7 - p. 1102-1110 , 2007

Link: https://doi.org/10.1038/..

14

Integrated physiology and pathophysiology of CB1-mediated e..:

Piazza, P.V. ; Lafontan, M. ; Girard, J.
Diabetes & Metabolism. 33 (2007) 2 - p. 97-107 , 2007

Link: https://doi.org/10.1016/..

15

Effects of CB1 antagonist on the control of metabolic funct..:

Lafontan, M. ; Piazza, P.V. ; Girard, J.
Diabetes & Metabolism. 33 (2007) 2 - p. 85-95 , 2007

Link: https://doi.org/10.1016/..